Overall, these results support the crucial role of aberrant angiogenesis across the pathogenic processes underlying SSc since the earliest phases, throughout the development of established disease, along with providing further support for the correlation between serum Ang2 concentrations and SSc-ILD. The gene discussed is ANGPT2; the disease is interstitial lung disease.